Person Centered Nursing Homes: Impact Assessment Of Centered Person Care In Nursing Homes (RECENPE)

Residències Centrades en Les Persones (RECENPE): avaluació de l'Impacte d'un Model d'ACP en residències Per Persones Grans

Cohort Observational Study. The study will assess differences in quality of life, well-being and mood between persons living in a nursing home following usual care and persons living in nursing homes following a centered person care model.

Initially, the follow up will last 6 months, with the possibility to be extended.

Study Overview

• Status: Unknown
• Conditions: Quality of Life; Mood; Health Services for the Aged
• Intervention / Treatment: Other: ACP intervention

• Study Type: Observational
• Enrollment (Anticipated): 170

Contacts and Locations

Study Locations

• Spain
  • Barcelona
    • Sant Sadurní d'Anoia, Barcelona, Spain, 08770
      • Residència "Casa del Avis"
  • Girona
    • Sant Hilari Sacalm, Girona, Spain, 17403
      • Residència i Centre de dia Sant Hilari

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Child; Adult; Older Adult
• Accepts Healthy Volunteers: No
• Genders Eligible for Study: All

• Sampling Method: Non-Probability Sample

Study Population

Persons of any age with or without cognitive impairment living indefinitely in a nursing home

Description

Inclusion Criteria:

• Persons living in nursing homes
• Consent from the person (or legal representative, if the person is not able)

Exclusion Criteria:

• Terminal illness
• Living temporary in a nursing home

Study Plan

How is the study designed?

Number of groups / cohorts

1

Cohorts and Interventions

Group / Cohort

Intervention / Treatment

Control; The control group is made by persons living in nursing homes under usual care

Other: ACP intervention; The intervention group made by persons living in nursing homes using a person centered attention model relying on two dimensions: - Attention to the person based on:Knowledge of the person in several dimensions (biological, psychological, social, etc), interests and preferences.Respect and acknowledge of the person.Promotion of the autonomy.Personalized treatment, with tailored attention and integrative curesProtection of physical well-being, preventing damages and risks and promoting healthy habits.Promotion of independence on daily activities.Protection of privacy and personal matters; - Positive environment based on:Physical space, including accessibility, comfort, homely environment, with stimulating spaces for physical activity, social relationships and significant activities for the persons.Social relationships, with proximity and collaboration with families.Friendly organization, with empathetic professionals empowering users.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Thriving in nursing homes	Thriving in nursing homes will be assessed with the Thriving of Older People Assessment Scale (TOPAS). Investigators will assess the change between groups.	0, 6 months
Quality of life	Quality of life will be assessed with the Euroqol 5D-5L. Investigators will assess the change between groups.	0, 6 months
Well-being	Well-being will be assessed by the WHO (Five) Well Being Index (1998 version). Investigators will assess the change between groups.	0, 6 months

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Depressive symptoms	Cognitive impairment affects the assessment of depressive symptoms. For this reason, according to their stage using the Reisberg Global Deterioration Scale, investigators will assess the presence or absence of depressive symptoms with two tools; stage 0 to 4: investigators will consider that a person has depressive symptoms with a score of 6 or more using the 15 items Yesavage Geriatric Depression Scale,; stage 5 to 7: investigators will consider that a person has depressive symptoms with a score of 11 or more using the Cornell Depression Scale. Investigators will assess the change in the prevalence of depressive symptoms between groups.	0, 6 months
Neuropsychiatric inventory	Neuropsychiatric symptoms will be assessed with the Brief Neuropsychiatric inventory(NPI-Q). Investigators will assess the change between groups.	0,6 months

Collaborators and Investigators

• Sponsor: Fundacio Salut i Envelliment UAB
• Collaborators: SUMAR empresa d'acció social de Catalunya
• Investigators: Principal Investigator: Xavier Rojano Luque, MD, Fundacio Salut i Envelliment UAB

Study record dates

Study Major Dates

• Study Start (Anticipated): June 27, 2017
• Primary Completion (Anticipated): February 1, 2018
• Study Completion (Anticipated): February 1, 2018

Study Registration Dates

• First Submitted: June 20, 2017
• First Submitted That Met QC Criteria: June 26, 2017
• First Posted (Actual): June 27, 2017

Study Record Updates

• Last Update Posted (Actual): June 27, 2017
• Last Update Submitted That Met QC Criteria: June 26, 2017
• Last Verified: June 1, 2017

More Information

Terms related to this study

• Other Study ID Numbers: FSIE1704; CEEAH - 3786 (Other Identifier: Comissió d'Ètica Animal en Experimentació i Humana)

Plan for Individual participant data (IPD)

• Plan to Share Individual Participant Data (IPD)?: UNDECIDED

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No